Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02854033 · ClinicalTrials.gov registry record
Alzheimer's Disease Neuroimaging Initiative 3
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 1,141
- Enrollment target
NCT02854033: Completed study, sponsored by University of Southern California.
NCT02854033 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 1,141 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02854033 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 1,141 participants
- Enrollment target
Study Summary
Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer's disease (AD). The overall goal of the study is to continue to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in AD research.
Primary Outcome
The ADAS-Cog is an in-person examiner-administered, structured scale that evaluates memory (word recall, word recognition), reasoning (following commands), language (naming, comprehension), orientation, ideational praxis (placing letter in envelope) and constructional praxis (copying geometric designs). Ratings of spoken language, language comprehension, word finding difficulty, and ability to remember test instructions are also obtained.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,141 participants |
| Start Date | 2016-12-02 |
| Est. Completion | 2024-05-28 |
What the finished NCT02854033 record still lists
NCT02854033 is an observational study that tracks outcomes without assigning an intervention. Its 1,141 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02854033 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02854033 about?
NCT02854033 is a clinical study titled "Alzheimer's Disease Neuroimaging Initiative 3". Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/private collaboratio...
What is the current status of trial NCT02854033?
This trial is currently completed. The enrollment target is 1,141 participants. The study started on 2016-12-02. Estimated completion is 2024-05-28.
Who is sponsoring clinical trial NCT02854033?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI